constipation while on semaglutide Ozempic & the Gut: What GLP-1 Medications Really Do to Your Digestive System | Board Certified Gastroenterologist, Hepatologist & Weight Loss Specialist located in Managing Constipation While Using Semaglutide

[DOI] [PubMed] [Google Scholar] 603.Silvestre R.A., Peiro E., Degano P., Miralles P., Marco J

Current treatments offer meaningful benefits while awaiting new options Experience with existing medications provides useful insights for future treatment Addressing underlying health conditions improves outcomes with any intervention Lifestyle modifications enhance and sustain pharmaceutical treatment effects Building healthy habits now prepares you for optimal future results Key Takeaways Retatrutide is a novel triple-agonist medication targeting GLP-1, GIP, and glucagon receptors simultaneously for comprehensive weight management Phase 2 clinical trials demonstrated up to 24% weight loss, potentially exceeding results seen with current market-leading medications like Mounjaro and Wegovy The glucagon receptor component may increase energy expenditure and fat burning, addressing both sides of the energy balance equation UK availability is expected around 2026-2027 following completion of Phase 3 trials and regulatory approval processes While waiting for Retatrutide, optimising current treatments and establishing healthy lifestyle foundations prepares you for future options When to Seek Professional Advice Navigating the evolving landscape of weight loss treatments can feel overwhelming, and professional guidance is invaluable for making informed decisions about your health

It makes the body produce insulin, stops another hormone called glucagon, and slows down how fast food leaves the stomach

These hormones help to reduce hunger and cravings, making it easier for people to stick with their diet and exercise plan

Please enter value between 10.0 and 500.0 ( one decimal )

Semaglutide can help weight loss patients shed stubborn pockets of extra fat